Sexually transmitted infections among HIV-1-discordant couples

PLoS ONE

Volumn 4, Issue 12, 2009, Pages

  Guthrie, Brandon L ^a   Kiarie, James N ^b   Morrison, Susan ^a   John Stewart, Grace C ^a   Kinuthia, John ^b   Whittington, William L H ^a   Farquhar, Carey ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANDIDIASIS; CHLAMYDIASIS; DISEASE TRANSMISSION; EDUCATIONAL STATUS; FEMALE; GENITAL ULCER; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TRICHOMONIASIS; UNSAFE SEX; VAGINITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; HERPES SIMPLEX VIRUS 2; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; VIROLOGY;

CHLAMYDIA; HUMAN HERPESVIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; DEMOGRAPHY; FEMALE; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MALE; PREVALENCE; SEXUAL BEHAVIOR; SEXUAL PARTNERS; SEXUALLY TRANSMITTED DISEASES;

EID: 77949517158     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008276     Document Type: Article

References (53)

1. Montaner JS, Hogg R, Wood E, Kerr T, Tyndall M, et al. (2006) The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 368: 531-536.
2. Bunnell R, Ekwaru JP, Solberg P, Wamai N, Bikaako-Kajura W, et al. (2006) Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda. AIDS 20: 85-92.
3. Auvert B, Males S, Puren A, Taljaard D, Carael M, et al. (2004) Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. J Acquir Immune Defic Syndr 36: 613-621.
4. Baggaley RF, Ferguson NM, Garnett GP (2005) The epidemiological impact of antiretroviral use predicted by mathematical models: a review. Emerg Themes Epidemiol 2: 9.
5. Gray RH, Li X, Wawer MJ, Gange SJ, Serwadda D, et al. (2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941-1951.
6. UNAIDS (2007) AIDS epidemic update: December 2007. Geneva, Switzerland: WHO. 50 p.
7. Baryarama F, Bunnell R, McFarland W, Hudes ES, Neilands TB, et al. (2007) Estimating HIV incidence in voluntary counseling and testing clients in Uganda (1992-2003). J Acquir Immune Defic Syndr 44: 99-105.
8. Lingappa JR, Lambdin B, Bukusi EA, Ngure K, Kavuma L, et al. (2008) Regional differences in prevalence of HIV-1 discordance in Africa and enrollment of HIV-1 discordant couples into an HIV-1 prevention trial. PLoS ONE 3: e1411.
9. Were WA, Mermin JH, Wamai N, Awor AC, Bechange S, et al. (2006) Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 43: 91-95.
10. Robinson NJ, Mulder D, Auvert B, Whitworth J, Hayes R (1999) Type of partnership and heterosexual spread of HIV infection in rural Uganda: results from simulation modelling. Int J STD AIDS 10: 718-725.
11. Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, et al. (2008) New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 371: 2183-2191.
12. UNAIDS (2005) AIDS epidemic update: December 2005. Geneva: UNAIDS. 98 p.
13. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, et al. (2005) Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 191: 1403-1409.
14. Fleming DT, Wasserheit JN (1999) From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75: 3-17.
15. Cohen MS (1998) Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 351 Suppl 3: 5-7.
16. Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Jr., et al. (2008) Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PLoS ONE 3: e2230.
17. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, et al. (1993) Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7: 95-102.
18. McClelland RS, Sangare L, Hassan WM, Lavreys L, Mandaliya K, et al. (2007) Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. J Infect Dis 195: 698-702.
19. Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, et al. (2001) The effect of treatment of vaginal infections on shedding of human immunodefi- ciency virus type 1. J Infect Dis 183: 1017-1022.
20. Wald A, Link K (2002) Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 185: 45-52.
21. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, et al. (2006) Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20: 73-83.
22. Hira SK, Feldblum PJ, Kamanga J, Mukelabai G, Weir SS, et al. (1997) Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STD AIDS 8: 243-250.
23. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, et al. (1991) Cofactors in male-female sexual transmission of human immunodefi- ciency virus type 1. J Infect Dis 163: 233-239.
24. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, et al. (2000) Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 342: 921-929.
25. Cohen MS, Hoffman IF, Royce RA, Kazembe P, Dyer JR, et al. (1997) Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet 349: 1868-1873.
26. Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, et al. (1997) The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 11: F85-93.
27. Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, et al. (1995) Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 346: 530-536.
28. Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Paxton L, et al. (1998) A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS 12: 1211-1225.
29. Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya-Kayondo J, et al. (2003) Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 361: 645-652.
30. Sangani P, Rutherford G, Wilkinson D (2004) Population-based interventions for reducing sexually transmitted infections, including HIV infection. Cochrane Database Syst Rev. pp CD001220.
31. Golden MR, Ashley-Morrow R, Swenson P, Hogrefe WR, Handsfield HH, et al. (2005) Herpes simplex virus type 2 (HSV-2) Western blot confirmatory testing among men testing positive for HSV-2 using the focus enzyme-linked immunosorbent assay in a sexually transmitted disease clinic. Sex Transm Dis 32: 771-777.
32. Ashley RL, Militoni J, Lee F, Nahmias A, Corey L (1988) Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol 26: 662-667.
33. Huppert JS, Mortensen JE, Reed JL, Kahn JA, Rich KD, et al. (2007) Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women. Clin Infect Dis 45: 194-198.
34. Benjamini Y, Hochberg Y (1995) Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Sciety Series B (Methodological) 57: 289-300.
35. Kissinger P, Secor WE, Leichliter JS, Clark RA, Schmidt N, et al. (2008) Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV- negative women. Clin Infect Dis 46: 994-999.
36. WHO (2005) Sexually transmitted and other reproductive tract infections: A guide to essential practice. Geneva: World Health Organization. 191 p.
37. Klinger EV, Kapiga SH, Sam NE, Aboud S, Chen CY, et al. (2006) A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania. Sex Transm Dis 33: 712-718.
38. Mason PR, Fiori PL, Cappuccinelli P, Rappelli P, Gregson S (2005) Seroepidemiology of Trichomonas vaginalis in rural women in Zimbabwe and patterns of association with HIV infection. Epidemiol Infect 133: 315-323.
39. Buve A, Weiss HA, Laga M, Van Dyck E, Musonda R, et al. (2001) The epidemiology of trichomoniasis in women in four African cities. AIDS 15 Suppl 4: S89-96.
40. Painter TM (2001) Voluntary counseling and testing for couples: a high-leverage intervention for HIV/AIDS prevention in sub-Saharan Africa. Soc Sci Med 53: 1397-1411.
41. Desgrees-du-Lou A, Orne-Gliemann J (2008) Couple-centred testing and counselling for HIV serodiscordant heterosexual couples in sub-Saharan Africa. Reprod Health Matters 16: 151-161.
42. Kamenga M, Ryder RW, Jingu M, Mbuyi N, Mbu L, et al. (1991) Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in Zaire. AIDS 5: 61-67.
43. Allen S, Karita E, Chomba E, Roth DL, Telfair J, et al. (2007) Promotion of couples' voluntary counselling and testing for HIV through influential networks in two African capital cities. BMC Public Health 7: 349.
44. Chomba E, Allen S, Kanweka W, Tichacek A, Cox G, et al. (2008) Evolution of couples' voluntary counseling and testing for HIV in Lusaka, Zambia. J Acquir Immune Defic Syndr 47: 108-115.
45. The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000) Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomised trial. Lancet 356: 103-112.
46. Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, et al. (2004) Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. J Acquir Immune Defic Syndr 37: 1620-1626.
47. Maman S, Mbwambo JK, Hogan NM, Weiss E, Kilonzo GP, et al. (2003) High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav 7: 373-382.
48. Butler DM, Smith DM, Cachay ER, Hightower GK, Nugent CT, et al. (2008) Herpes simplex virus 2 serostatus and viral loads of HIV-1 in blood and semen as risk factors for HIV transmission among men who have sex with men. AIDS 22: 1667-1671.
49. Corey L, Wald A, Patel R, Sacks SL, Tyring SK, et al. (2004) Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 350: 11-20.
50. Celum C, Wald A, Hughes J, Sanchez J, Reid S, et al. (2008) Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 371: 2109-2119.
51. Wald A, Krantz E, Selke S, Lairson E, Morrow RA, et al. (2006) Knowledge of partners' genital herpes protects against herpes simplex virus type 2 acquisition. J Infect Dis 194: 42-52.
52. Weiss HA, Buve A, Robinson NJ, Van Dyck E, Kahindo M, et al. (2001) The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 15 Suppl 4: S97-108.
53. Abu-Raddad LJ, Longini IM, Jr. (2008) No HIV stage is dominant in driving the HIV epidemic in sub-Saharan Africa. AIDS 22: 1055-1061.